Who makes Sildenafil and Boceprevir?

Sildenafil and Boceprevir is developed by Imperial College London.

What development phase is Sildenafil and Boceprevir in?

Sildenafil and Boceprevir is in Phase 1.

Last reviewed 2026-05-13 · How we verify

Sildenafil and Boceprevir

Imperial College London · Phase 1 active Small molecule

At a glance

Generic name	Sildenafil and Boceprevir
Also known as	Viagra and Victrelis
Sponsor	Imperial College London
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

The Boceprevir and Sildenafil Pharmacokinetics Study (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Sildenafil and Boceprevir CI brief — competitive landscape report
Sildenafil and Boceprevir updates RSS · CI watch RSS
Imperial College London portfolio CI